US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Royalty Pharma PLC (RPRX)
Royalty Pharma PLC (RPRX) ニュース

RPRX

Royalty Pharma (RPRX)

Royalty Pharma PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RPRX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/11	05 : 58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/06/07	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/06/05	06 : 12	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RPRX	Royalty Pharma PLC
2024/06/05	05 : 57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/06/05	05 : 15	GlobeNewswire Inc.	Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:RPRX	Royalty Pharma PLC
2024/06/04	06 : 15	GlobeNewswire Inc.	Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes	NASDAQ:RPRX	Royalty Pharma PLC
2024/06/04	05 : 59	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NASDAQ:RPRX	Royalty Pharma PLC
2024/06/03	22 : 13	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RPRX	Royalty Pharma PLC
2024/06/03	21 : 39	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/30	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/28	20 : 10	GlobeNewswire Inc.	Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/23	05 : 10	GlobeNewswire Inc.	Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/23	05 : 00	GlobeNewswire Inc.	Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/17	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/13	21 : 15	GlobeNewswire Inc.	Royalty Pharma to Present at Upcoming Investor Conferences	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/09	22 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/09	20 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/09	20 : 00	GlobeNewswire Inc.	Royalty Pharma Reports First Quarter 2024 Results	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/09	19 : 45	GlobeNewswire Inc.	Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab	NASDAQ:RPRX	Royalty Pharma PLC
2024/04/19	21 : 15	GlobeNewswire Inc.	Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024	NASDAQ:RPRX	Royalty Pharma PLC
2024/04/17	21 : 15	GlobeNewswire Inc.	Royalty Pharma Declares Second Quarter 2024 Dividend	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/29	06 : 15	GlobeNewswire Inc.	Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/15	23 : 05	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/15	21 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/15	21 : 30	GlobeNewswire Inc.	Royalty Pharma Reports Q4 and Full Year 2023 Results	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/06	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/31	06 : 15	GlobeNewswire Inc.	Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/19	22 : 15	GlobeNewswire Inc.	Royalty Pharma Announces Dividend Increase	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/08	21 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/08	21 : 00	GlobeNewswire Inc.	Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:RPRX	Royalty Pharma PLC

Showing the most relevant articles for your search:NASDAQ:RPRX

1 2 3 4 5 6 7 8 9 10 次へ >>

Financial Select Sector

US Dollar vs Euro

US Dollar vs Yen

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約